CDKN2A, which is closely related to the maintenance of copper metabolic homeostasis in the body, is a biomarker of HNSCC and may improve its prognosis by regulating the cell cycle and immune cell infiltration. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.